Memorial Sloan Kettering Suffolk-Commack

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-06-22		NCT05756777
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma	Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, adrenal cortex carcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm	Recruiting	Phase 2	2026-04-15		NCT06066333

Clinical trials